Modulation of carcinogen bioavailability by immunisation with benzo[a]pyrene-conjugate vaccines

Vaccine

Volumn 27, Issue 31, 2009, Pages 4142-4151

  Grova, Nathalie ^a   Prodhomme, Emmanuel J F ^a   Schellenberger, Mario T ^a   Farinelle, Sophie ^a   Muller, Claude P ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Benzo a pyrene; Bioavailability; Mice; Specific antibodies

Indexed keywords

BENZO[A]PYRENE; BENZO[A]PYRENE DIPHTHERIA TOXIN CONJUGATE VACCINE; BENZO[A]PYRENE OVALBUMIN CONJUGATE VACCINE; BENZO[A]PYRENE TETANUS TOXOID CONJUGATE VACCINE; CARCINOGEN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BIOAVAILABILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; METABOLIC ACTIVATION; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 67349287794     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.052     Document Type: Article

References (40)

1. Bismuth C., Borron S.W., Baud F.J., Taboulet P., and Scherrmann J.M. Immunotoxicotherapy: successes, disappointments and hopes. Hum Exp Toxicol 16 10 (1997) 602-608
2. Butler Jr. V.P., and Beiser S.M. Antibodies to small molecules: biological and clinical applications. Adv Immunol 17 (1973) 255-310
3. Silbart L.K., Rasmussen M.V., and Oliver A.R. Immunoprophylactic intervention in chemical toxicity and carcinogenicity. Vet Hum Toxicol 39 1 (1997) 37-43
4. De Buck S.S., Augustijns P., and Muller C.P. Specific antibody modulates absorptive transport and metabolic activation of benzo[a]pyrene across Caco-2 monolayers. J Pharmacol Exp Ther 313 2 (2005) 640-646
5. De Buck S.S., Bouche F.B., Brandenburger A., and Muller C.P. Modulation of the metabolism and adverse effects of benzo[a]pyrene by a specific antibody: a novel host factor in environmental carcinogenesis?. Carcinogenesis 26 4 (2005) 835-844
6. Rasmussen M.V., Barker T.T., and Silbart L.K. High affinity binding site-mediated prevention of chemical absorption across the gastrointestinal tract. Toxicol Lett 125 1-3 (2001) 51-59
7. Rasmussen M.V., and Silbart L.K. Peroral administration of specific antibody enhances carcinogen excretion. J Immunother 21 6 (1998) 418-426
8. Silbart L.K., Nordblom G., Keren D.F., Wise Jr. D.S., Lincoln P.M., and Townsend L.B. A rapid and sensitive screening method for the detection of anti-2-acetylaminofluorene immunoglobulins. J Immunol Methods 109 1 (1988) 103-112
9. De Buck S.S., and Muller C.P. Immunopropylactic approaches against chemical carcinogenesis. Vaccine 23 17-18 (2005) 2403-2406
10. Glushkov A.N., Anosova T.P., Anosov M.P., Zheleznova L.Y., and Nebesnaya N.G. Are there any interrelations between immunogenic activity of chemical carcinogens and tumour antigens in cancer patients?. Russ J Immunol 2 1 (1997) 49-54
11. Glushkov A.N., Anosova T.P., Kostyanko M.V., Anosov M.P., Polenok E.G., Cherno S.V., et al. Antisera to polycyclic aromatic hydrocarbons and their application on the detection of chemical carcinogens in blood sera of oncological patients. Exp Oncol 26 2 (2004) 145-148
12. Harris C.C., Vahakangas K., Newman M.J., Trivers G.E., Shamsuddin A., Sinopoli N., et al. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci USA 82 19 (1985) 6672-6676
13. Haugen A., Becher G., Benestad C., Vahakangas K., Trivers G.E., Newman M.J., et al. Determination of polycyclic aromatic hydrocarbons in the urine, benzo (a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res 46 8 (1986) 4178-4183
14. Newman M.J., Light B.A., Weston A., Tollurud D., Clark J.L., Mann D.L., et al. Detection and characterization of human serum antibodies to polycyclic aromatic hydrocarbon diol-epoxide DNA adducts. J Clin Invest 82 1 (1988) 145-153
15. Newman M.J., Weston A., Carver D.C., Mann D.L., and Harris C.C. Serological characterization of polycyclic aromatic hydrocarbon diolepoxide-DNA adducts using monoclonal antibodies. Carcinogenesis 11 11 (1990) 1903-1907
16. Jerina D.M., Sayer J.M., Yagi H., Croisy-Delcey M., Ittah Y., Thakker D.R., et al. Highly tumorigenic bay-region diol epoxides from the weak carcinogen benzo[c]phenanthrene. Adv Exp Med Biol 136 Pt A (1981) 501-523
17. Wislocki P.G., Wood A.W., Chang R.L., Levin W., Yagi H., Hernandez O., et al. High mutagenicity and toxicity of a diol epoxide derived from benzo (a)pyrene. Biochem Biophys Res Commun 68 3 (1976) 1006-1012
18. Poirier M.C. Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer 4 8 (2004) 630-637
19. Grova N., Feidt C., Laurent C., and Rychen G. [14C] Milk, urine and faeces excretion kinetics in lactating goats after an oral administration of [14C]polycyclic aromatic hydrocarbons. Int Dairy J 12 12 (2002) 1025-1031
20. Grova N., Schroeder H., Farinelle S., Prodhomme E., Valley A., and Muller C.P. Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-d-aspartate (NMDA) receptors genes in relevant brain regions. Chemosphere 73 1 Suppl. (2008) S295-S302
21. Lee B.M., and Strickland P.T. Antibodies to carcinogen-DNA adducts in mice chronically exposed to polycyclic aromatic hydrocarbons. Immunol Lett 36 2 (1993) 117-123
22. Glushkov A.N. Immunological mechanisms of adaptation to the low-weight chemical compounds in ontogenesis. Med Hypotheses 61 3 (2003) 405-411
23. Harlow E., and Lane D. Antibodies: a laboratory manual (1988), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (USA)
24. Junghans R.P. IgG biosynthesis: no "immunoregulatory feedback". Blood 90 10 (1997) 3815-3818
25. Hieda Y., Keyler D.E., Ennifar S., Fattom A., and Pentel P.R. Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain. Int J Immunopharmacol 22 10 (2000) 809-819
26. Hieda Y., Keyler D.E., VanDeVoort J.T., Niedbala R.S., Raphael D.E., Ross C.A., et al. Immunization of rats reduces nicotine distribution to brain. Psychopharmacology (Berl) 143 2 (1999) 150-157
27. Janoff E.N., Hardy W.D., Smith P.D., and Wahl S.M. Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. J Immunol 147 7 (1991) 2130-2135
28. Pentel P.R., Malin D.H., Ennifar S., Hieda Y., Keyler D.E., Lake J.R., et al. A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats. Pharmacol Biochem Behav 65 1 (2000) 191-198
29. Johansson A.G., Lovdal T., Magnusson K.E., Berg T., and Skogh T. Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats. Hepatology 24 1 (1996) 169-175
30. Skogh T., Blomhoff R., Eskild W., and Berg T. Hepatic uptake of circulating IgG immune complexes. Immunology 55 4 (1985) 585-594
31. Skogh T., Eskild W., Sundqvist T., and Berg T. Elimination kinetics of circulating antigens and immune complexes. II. Hepatic and extrahepatic elimination of chemically modified albumin preparations in relation to their non-specific physicochemical properties. J Clin Lab Immunol 27 1 (1988) 13-17
32. Steinberg P., Lafranconi W.M., and Oesch F. The distribution of carcinogen metabolizing enzymes in the mouse liver: comparison of parenchymal and non-parenchymal cell populations. Arch Toxicol Suppl 10 (1987) 148-156
33. Zhong Z., Goto M., Hijioka T., Oide H., Kauffman F.C., and Thurman R.G. Role of Kupffer cells in storage and metabolism of benzo (a)pyrene in the liver. Drug Metab Dispos 22 5 (1994) 680-687
34. Galati R., Crebelli R., Zijno A., Conti L., Falasca G., and Verdina A. The effect of humoral immunity against adducted benzo[a]pyrene on DNA damage elicited by acute carcinogen exposure in Swiss mice. In Vivo 14 6 (2000) 747-751
35. Verdina A., Zito R., Cortese G., Leopardi P., Marcon F., Zijno A., et al. Induction of humoral immunity toward 2-acetylaminofluorene in mice: modulation of DNA binding after 4 weeks dietary exposure to the carcinogen. Carcinogenesis 17 8 (1996) 1705-1709
36. International Programon Chemical Safety. Environmental Health Criteria 202 selected non-heterocyclic aromatic hydrocarbons, World Health Organisation, Genova; 1998. p. 540-43.
37. Menzie C.A., Potocki B.B., and Santodonato J. Exposure to carcinogenic PAHs in the environment. Environ Sci Technol 26 (1992) 1278-1284
38. Hollender J., Koch B., and Dott W. Biomonitoring of environmental polycyclic aromatic hydrocarbon exposure by simultaneous measurement of urinary phenanthrene, pyrene and benzo[a]pyrene hydroxides. J Chromatogr B Biomed Sci Appl 739 1 (2000) 225-229
39. Jacob J., and Grimmer G. Metabolism and excretion of polycyclic aromatic hydrocarbons in rat and in human. Cent Eur J Public Health 4 Suppl. (1996) 33-39
40. Sugihara N., and James M.O. Binding of 3-hydroxybenzo[a]pyrene to bovine hemoglobin and albumin. J Biochem Mol Toxicol 17 4 (2003) 239-247